10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT UNDER SECTION 13 0R 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: December 31, 2012

¨ TRANSITION REPORT UNDER SECTION 13 0R 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from:

Commission file number: 002-95626-D

SIONIX CORPORATION

(Exact name of registrant as specified in its charter)

Nevada	87-0428526
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.
914 Westwood Blvd., Box 801 Los Angeles, California	90024
(Address of principal executive offices)	(Zip Code)

Issuer’s telephone number (704) 971-8400

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period than the registrant was required to submit and post such files).  Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filed,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨	Accelerated filer ¨
Non-accelerated filer ¨ (Do not check if a smaller reporting company)	Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ¨ Yes x No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.  As of February 15, 2013 the number of shares of the registrant’s classes of common stock outstanding was 426,996,914.

Table of Contents

Part I - Financial Information	3
Item 1. Condensed Consolidated Financial Statements (Unaudited)	3
Balance Sheets as of December 31, 2012 and September 30, 2012	3
Statements of Operations for the three months ended December 31, 2012 and 2011	4
Statements of Cash Flows for the three months ended December 31, 2012 and 2011	5
Notes to financial statements	6
Forward-Looking Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	13
Item 3. Quantitative and Qualitative Disclosures About Market Risk	16
Item 4. Controls and Procedures	16
Part II – Other Information	16
Item 1. Legal Proceedings	16
Item 1A. Risk Factors	16
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	16
Item 3. Defaults Upon Senior Securities	16
Item 4. Mine Safety Disclosure	17
Item 5. Other Information	17
Item 6. Exhibits	17
Signatures	18

2

Part I, Item 1.  Financial Statements.

Sionix Corporation

Condensed Consolidated Balance Sheets

(Unaudited)

	As of December 31, 2012			As of September 30, 2012
ASSETS
Current assets:
Cash and cash equivalents	$	140,235		$	1,348,069
Other receivable		11,496			27,854
Inventory		1,411,484			1,311,349
Other current assets		165,785			91,529
Total current assets		1,729,000			2,778,801
Non-current assets:
Property and equipment, net		80,400			128,119
Total assets	$	1,809,400		$	2,906,920
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable	$	113,369		$	155,547
Accrued expenses		944,733			907,728
Notes payable - related parties		25,000			25,000
Convertible notes, net of debt discount		1,983,358			1,895,378
Secured promissory notes		64,027			225,681
Deferred Revenue		10,000			10,000
Derivative liability		420,028			638,178
Shares to be issued		68,184			165,880
Total current liabilities		3,628,699			4,023,392
Long-Term Debt, net of discount		700,000			-
Total Liabilities	$	4,328,699		$	4,023,392
Stockholders' Deficit
Stockholders' Deficit Attributable to Sionix Corporation:
Preferred stock, $0.001 par value, 10,000,000 shares authorized at December 31, 2012					-
Common stock, $0.001 par value (600,000,000 shares authorized; 417,021,530 shares issued and outstanding at December 31, 2012; 387,968,434 shares issued and outstanding at September 30, 2012)		417,022			387,968
Additional paid-in capital		35,681,588			34,807,672
Accumulated deficit		(38,617,909	)		(37,560,000	)
Total stockholders' deficit attributable to Sionix Corporation		(2,519,299	)		(2,364,360	)
Equity attributable to noncontrolling interest		-			1,247,888
Total stockholders' deficit		(2,519,299	)		(1,116,472	)
Total liabilities and stockholders' deficit	$	1,809,400		$	2,906,920

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

Sionix Corporation

Condensed Consolidated Statement of Operations

Unaudited

	Three Months Ended December 31,
	2012			2011
Operating expenses
General and administrative	$	502,864		$	785,621
Sales and marketing		47,716			85,425
Research and development		280,845			143,292
Depreciation		10,068			3,506
Total operating expenses		841,493			1,017,844
Loss from operations		(841,493	)		(1,017,844	)
Other income (expense)
Interest expense and financing costs		(296,410	)		(218,894	)
Gain (loss) on change in fair value of derivative liability		78,191			325
Loss on sale of property and equipment		(2,228	)		-
Gain on settlement of debt		4,031			41,911
Total other income (expense)		(216,416	)		(176,658	)
Loss before income taxes		(1,057,909	)		(1,194,502	)
Income taxes		-			-
Net loss	$	(1,057,909	)	$	(1,194,502	)
Basic loss per share	$	(0.00	)	$	(0.00	)
Diluted loss per share	$	(0.00	)	$	(0.00	)
Basic weighted average number of shares of common stock outstanding		399,961,376			304,868,562
Diluted weighted average number of shares of common stock outstanding		399,961,376			304,868,562

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

Sionix Corporation

Condensed Consolidated Statements of Cash Flows

Three Months Ending December 31, 2012 and 2011

	2012			2011
Cash flows from operating activities
Net loss	$	( 1,057,909	)	$	(1,194,502	)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation		10,068			3,506
Amortization of debt discounts		228,037			100,983
Share based payments		14,671			103,932
Common stock issued for services		215,078			239,500
(Gain) loss on change in fair value of derivative liability		(78,191	)		(325	)
Loss on sale of property and equipment		2,228			-
Gain on settlement of debt		(4,031	)		(41,911	)
Changes in operating assets and liabilities:
Inventory		(100,135	)		(16,871	)
Other current assets		(100,864	)		(264,661	)
Accounts payable		(129,760	)		51,650
Accrued expenses		54,073			398,027
Deferred revenue		-			-
Net cash used by operating activities		(946,735	)		(620,672	)
Cash flows from investing activities:
Proceeds from sale of property and equipment		41,171			-
Purchase of property and equipment		(5,748	)		-
Net cash provided by investing activities		35,423			-
Cash flows from financing activities:
Borrowings		273,125			491,500
Common stock issued for cash		-			150,200
Cash issued in redemption of subsidiary interests		(569,647	)		-
Net cash (used) provided by financing activities		(296,522	)		641,700
Net (decrease) increase in cash and cash equivalents		(1,207,834	)		21,028
Cash and cash equivalents, beginning of period		1,348,069			685
Cash and cash equivalents, end of period	$	140,235		$	21,713
SUPPLEMENTARY CASH FLOW INFORMATION:
Income taxes paid	$	1,095		$	599
Interest paid	$	-		$	-
Debt issued in redemption of subsidiary interests	$	450,000		$	-

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

Sionix Corporation

Notes to Condensed Consolidated Unaudited Financial Statements

Note 1 – Organization and Description of Business

Sionix Corporation (the "Company") was incorporated in Utah in 1996.  The Company completed its reincorporation as a Nevada corporation effective July 1, 2003. Sionix designs, develops, markets and sells cost-effective water management and treatment solutions intended for use in the oil and gas, agriculture, industrial, disaster relief, and municipal (both potable and wastewater) markets. The Company’s Mobile Water Treatment System contains a Dissolved Air Floatation (“DAF”) system with patented technology that management estimates removes more than 99% of the organic, and most inorganic, particles in water.  Historically, DAF systems created bubbles that were 50+ microns in size, which were unable to remove all contaminants due to their size. The Sionix system utilizes and refines DAF technology to provide a pre-treatment process using ambient oxygen and minimal chemical flocculent aids that the Company believes is efficient and cost-effective. The patented Sionix technology makes micro-bubbles which allow a greater percentage of contaminants to be captured, floated to the surface and skimmed off, without harmful chemicals.

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies

In the opinion of management, the accompanying balance sheets and related interim statements of operations, and cash flows include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s annual report on Form 10-K for the fiscal year ended September 30, 2012 filed with the U.S. Securities and Exchange Commission (the “Commission”) on December 31, 2012.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  Significant estimates include collectability of accounts receivable, accounts payable, sales returns, and recoverability of long-term assets.

Consolidation

All significant intercompany accounts and balances have been eliminated in consolidation. Participation of other unit holders in the net assets and net earnings of consolidated subsidiaries is included in the captions ‘equity attributable to noncontrolling interest’ and ‘net loss attributable to the noncontrolling interest’ in the accompanying condensed consolidated balance sheet and condensed consolidated statement of operations, respectively.

Recently Issued Accounting Pronouncements

In December 2011, the FASB issued disclosure guidance related to the offsetting of assets and liabilities. The guidance requires an entity to disclose information about offsetting and related arrangements for recognized financial and derivative instruments to enable users of its financial statements to understand the effect of those arrangements on its financial position. The amended guidance is effective for us on a retrospective basis commencing in the first quarter of 2014. We are currently evaluating the impact of this new guidance on our consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-08, “Intangibles – Goodwill and Other (Topic 350): Testing Goodwill for Impairment.” ASU No. 2011-08 provides companies an option to perform a qualitative assessment to determine whether further goodwill impairment testing is necessary. If, as a result of the qualitative assessment, it is determined that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, the two-step quantitative impairment test is required. Otherwise, no further testing is required. ASU No. 2011-08 will be effective for the Company for goodwill impairment tests performed in the fiscal year ending September 30, 2013, with early adoption permitted. The adoption of this guidance is expected to have no impact on the Company’s consolidated financial condition and results of operations.

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220): Presentation of Comprehensive Income.” ASU No. 2011-05 eliminates the option to present components of other comprehensive income as part of the statement of shareholders’ equity. All non-owner changes in shareholders’ equity instead must be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Also, reclassification adjustments for items that are reclassified from other comprehensive income to net income must be presented on the face of the financial statements. ASU No. 2011-05 was effective for the Company for the quarter ending December 31, 2012. The adoption of this guidance had no impact on the Company’s financial condition and results of operations.

6

In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs.” ASU No. 2011-04 clarifies and changes the application of various fair value measurement principles and disclosure requirements, and was effective for the Company in the second quarter of fiscal 2012 (January 1, 2012). The adoption of this guidance had no impact on the Company’s consolidated financial condition and results of operations.

Note 3 – Property and Equipment

Property and equipment consisted of the following at:

	December 31, 2012			September 30, 2012
Machinery and equipment	$	128,509		$	166,159
Less accumulated depreciation		(48,109	)		(38,040	)
Property and equipment, net	$	80,400		$	128,119

Depreciation expense for the three months ended December 31, 2012 and 2011 was $10,068 and $3,506, respectively.

Note 4 – Accrued Expenses

Accrued expenses consisted of the following at:

	December 31, 2012		September 30, 2012
Accrued salaries	$	281,752	$	306,055
Interest payable		415,876		364,567
Other accrued expenses		247,105		237,106
Total accrued expenses	$	944,733	$	907,728

During the three months ended December 31, 2012, $13,032 of accrued interest was included in the conversion of notes payable into common stock described in Note 6.

Note 5 – Notes Payable – Related Parties

The Company has received advances in the form of unsecured promissory notes from stockholders. The original date of these advances was November 2009, March 2011 and October 2011. These notes bear interest at rates up to 10% and are due on demand. As of both December 31, 2012 and September 30, 2012, such notes payable amounted to $25,000. Accrued interest on the notes amounted to $20,356 and $19,717 at December 31, 2012 and September 30, 2012, respectively, and is included in accrued expenses. Interest expense on these notes for the three months ended December 31, 2012 and 2011 amounted to $639 and $639, respectively. No demand for payment has been made as of December 31, 2012.

Note 6 – Convertible Notes

At December 31, 2012 and September 30, 2012, convertible notes payable amounted to $1,983,358 and $1,895,378, respectively, net of discounts of $344,464 and $383,600 respectively. The notes bear interest at 6% - 12% per annum, and are convertible into common stock of the Company at $0.02 - $0.15 per share (as well as variable conversion rates as described below). The notes are due at various dates through September 2014 and are unsecured.

7

Unsecured Convertible Notes:

Through December 31, 2012, the Company issued $700,000 of convertible debentures (of which $87,500 is outstanding at December 31, 2012) that are convertible into common stock of the Company at variable conversion rates that provide a fixed rate of return to the note-holder. Under the terms of the notes, however, the Company could be required to issue additional shares of common stock in the event of default. The Company applied the provisions of ASC Topic 815, “Derivatives and Hedging” and determined that the conversion option should be bifurcated from the notes and valued separately. This conversion option has been recorded as a derivative liability, is being amortized over the terms of the related notes, and is carried at fair value in the accompanying balance sheet. During the three months ended December 31, 2012 and 2011, the change in fair value of this derivative liability amounted to $78,191 and $325, respectively.

During the three months ended December 31, 2012, holders of convertible debentures elected to convert $82,500 of their debt plus accrued interest into 8,569,317 shares of common stock.

6% Convertible Redeemable Note:

On November 23, 2011 Sionix issued a 6% Convertible Redeemable Note in the principal amount $100,000 maturing on November 23, 2012. In addition, the Company received a commitment in the form of a promissory note from the lender pursuant to which the lender provided the Company with funding of up to an additional $300,000 beginning on June 1, 2012, at which time $100,000 became available, on each of June 1, 2012, July 1, 2012 and August 1, 2012 (the "Additional Financing"). All funds were advanced as agreed for a total of $400,000. Sionix paid fees of $45,000 in connection with the funding of these loans. The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.

For the period ending December 31, 2012 there was $36,600 outstanding on these Notes.

On September 21, 2012 Sionix issued a 6% Convertible Redeemable Note in the principal amount $100,000 to GEL Properties.  The note matures on September 21, 2013.  The Company has an optional right of redemption prior to maturity upon a five-day notice and payment of a 50% premium on the unpaid principal amount of the loan.  The Company paid fees of $6,000 in connection with the funding of this loan. In addition, the Company received a commitment in the form of a promissory note from GEL Properties pursuant to which it will provide Sionix with funding of an additional $300,000, $100,000 of which will become available on each of July 1, 2013, August 15, 2013 and October 1, 2013.  The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.

For the period ending December 31, 2012 there was $100,000 outstanding on these Notes.

10% Convertible Debentures:

On September 29, 2012 the Company entered into a securities purchase agreement dated September 25, 2012 with several accredited investors (“Holders”) for the purchase and sale of $1,025,000 of its convertible notes (“Notes”) and warrants.    The Notes bear interest at the rate of 10% per annum beginning as of September 25, 2012, and mature on June 25, 2013.  On the closing date, the Company paid and the Holders received nine months of pre-paid interest on the original principal amount of the Notes (based on the agreed nine-month term of the Notes).

The Notes are convertible at any time at the option of the Holders into the Company’s common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request, however the conversion price may not exceed $0.04, and may not be lower than $0.02 per share.  The Notes may be redeemed by the Company at any time prior to maturity with ten days’ prior notice to the Holders, and payment of a premium of 25% on the unpaid principal amount of the Notes.  In addition the Notes and related securities purchase agreement contain representations, warranties and covenants that are customary for financings of this type.

The Company issued warrants to the Holders for the purchase of up to 23,125,000 shares of Company common stock, pro rata in proportion to the amount invested, which can be exercised for a period of five years from the closing date, with a fixed exercise price of $0.08 per share.

The Company agreed to register the common stock into which the Notes may be converted, any shares of common stock that may be issued as payment of principal or interest, and the common stock underlying the warrants, as well as any shares of common stock that may be issued as a result of any stock split, dividend or other distribution. The Company agreed to file an initial registration statement within 30 days of the date of the registration rights agreement.  If the Company fails to file a registration statement within this 30 day period, or to have it declared effective within 90 days after the date of the registration rights agreement, or to maintain its effectiveness (in addition to other events described in the full text of the registration rights agreement), the Company will be obligated to pay the investors liquidated damages equal to 2% of the principal amount of the Notes per month until the event is cured, for up to one year, and 1% per month thereafter if the event continues uncured

8

The offering was made with the services of a placement agent.  At the closing of the sale and issuance of the Notes, the Company paid a cash fee to the placement agent in the amount of $87,535 or 8.54% of the gross proceeds of the offering.

Note 7 – 12% Secured Promissory Note

On November 8, 2011 Sionix issued a 12% Secured Promissory Note in the principal amount of $300,000 maturing on July 31, 2012. The Company had an optional right of redemption prior to maturity. Sionix was to redeem the debenture on the maturity date at a redemption premium of 7.5%. Sionix granted to the investor a continuing, first priority security interest in certain property of Sionix to secure the prompt payment, performance, and discharge in full of all of the Company’s obligations under the Secured Promissory Note, Securities Purchase Agreement, and Pledge Agreement.

In connection with this borrowing, Sionix issued 2,358,491 shares of common stock as Incentive Shares, and 16,981,132 shares of common stock as Pledged Shares. At the Company’s option, the Incentive Shares may be redeemed for cash in the amount of $125,000; otherwise they are retained by the lender. The value of the Incentive Shares has been classified as a liability and is being amortized as interest expense over the term of the borrowing. The Pledged Shares were issued as security under the Pledge Agreement.

The Company is continuing to issue shares to reduce the outstanding balance, and no default based on the elapsed maturity date has been declared by the note holder.  After conversions, the amount outstanding as of December 31, 2012 amounted to $64,027.

Note 8 – Long Term Debt

10% Convertible Debt (WBI):

On November 26, 2012 Sionix completed the repurchase of all outstanding membership interests in WBI.  In return for their membership interests and the release of WBI from any future claims, the Company offered the members the option of receiving a pro-rata share of the remaining capital invested into WBI, or they could assign their rights to their remaining capital to Sionix in return for a convertible note issued by Sionix equal to 100% of their original investment. The pro-rata share calculation did not include Sionix's interest in WBI. The cash available for distribution totaled $854,046 or 63.3% of the original investment of $1,350,000. The Company returned $569,649 of the original capital invested, representing an original investment of $900,000.

The Company issued convertible notes in the amount of $450,000 and received $284,397 of the remaining capital.  In addition, the Company received $250,000 of new capital in return for the issuance of an additional note of $394,000, and recognized a debt discount of $144,000 in connection with this new note.

The convertible notes issued mature on September 30, 2014, bear an annual interest rate of 10% payable in cash or in kind at our election, and are convertible at the election of the holder into common shares of Sionix at a rate of $0.04.

As part of this offering, the Company paid a placement agent a fee of $45,000 for services rendered in connection with this transaction.

Note 9 – Income Taxes

For the three months ended December 31, 2012, the accompanying Condensed Consolidated Statements of Operations reflect net income that is largely comprised of items that do not represent taxable income.

Note 10 – Stockholders’ Equity

Common Stock

The Company has 600,000,000 authorized shares of common stock, par value $0.001 per share. As of December 31, 2012, the Company had 417,021,530 shares issued and outstanding. As of September 30, 2012, the Company had 387,968,434 shares of common stock issued and outstanding.

During the three months ended December 31, 2012, the Company issued 7,314,379 shares of common stock for services to officers, directors and consultants (valued at $215,078) based on closing market prices. The Company also issued 21,738,717 shares of common stock for conversion of debt in the amount of $433,764 (including interest).

9

Employee Stock Options and Warrants

A summary of the Company’s activity for employee stock options and warrants:

	Number of Options			Weighted  Average  Exercise Price		Aggregate Intrinsic Value		Weighted  Average  Remaining  Contractual Life
Outstanding at October 1, 2012		43,716,316		$	0.12	$	-		3.01
Granted		500,000			0.15		-		4.75
Expired		(3,933,526	)		0.21		-		-
Forfeited		(500,000	)		0.15		-		-
Exercised		-			-		-		-
Outstanding at December 31, 2012		39,782,790			0.11		-		2.22
Exercisable at December 31, 2012		39,782,790		$	0.11	$	-		2.21

Outstanding and exercisable as of December 31, 2012:

	Exercise Price	Options Outstanding		Contractual Life		Weighted Average Remaining Options Exercisable		Weighted Average Remaining Contractual Life
$	0.06		7,415,000		2.68		7,366,260		2.66
$	0.07		2,000,000		3.00		2,000,000		3.00
$	0.09		2,000,000		3.00		2,000,000		3.00
$	0.10		8,416,850		1.76		8,416,850		1.76
$	0.12		8,450,940		1.28		8,450,940		1.28
$	0.14		500,000		3.42		158,356		1.08
$	0.15		11,000,000		2.66		11,000,000		2.66
			39,782,790		2.22		39,392,406		2.21

During the three months ended December 31, 2012, the Company granted a total of 500,000 options and warrants to certain officers and employees. The options and warrants vested immediately upon grant and have a term of five years. The weighted average grant-date fair value of these options and warrants was $14,671.   The fair value of these options and warrants was estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

● risk free rate of return of 0.72%;

● volatility of 171%

● dividend yield of 0%; and

● expected term of 5 years.

10

Stock Warrants

A summary of the Company’s warrant activity with non-employees:

	Number of Warrants			Weighted  Average  Exercise Price		Aggregate Intrinsic Value
Outstanding at October 1, 2012		114,460,085		$	0.12	$	75,000
Granted		625,000			0.08		-
Expired		(4,223,182	)		0.26		-
Forfeited		-			-		-
Exercised		-			-		-
Outstanding as of December 31, 2012		110,861,903		$	0.13	$	75,000
Exercisable as of December 31, 2012		110,861,903		$	0.12	$	75,000

Warrants outstanding and exercisable as of December 31, 2012:

						Weighted
						Average
						Remaining		Weighted Average
	Exercise	Warrants		Warrants		Contractual		Exercise Price
	Price	Outstanding		Exercisable		Life		Outstanding		Exercisable
$	0.06		7,500,000		7,500,000		3.38	$	0.06	$	0.06
$	0.07		22,833,333		22,833,333		1.29	$	0.07	$	0.07
$	0.08		25,425,000		25,425,000		4.73	$	0.08	$	0.08
$	0.10		6,726,578		6,726,578		3.11	$	0.10	$	0.10
$	0.12		6,226,000		6,226,000		0.93	$	0.12	$	0.12
$	0.14		5,000,000		5,000,000		2.81	$	0.14	$	0.14
$	0.15		2,107,667		2,107,667		1.83	$	0.15	$	0.15
$	0.17		27,993,325		27,993,325		2.90	$	0.17	$	0.17
$	0.18		850,000		850,000		0.03	$	0.18	$	0.18
$	0.25		3,700,000		3,700,000		1.02	$	0.25	$	0.25
$	0.30		2,500,000		2,500,000		0.35	$	0.30	$	0.30
			110,861,903		110,861,903

Note 11 – Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. This basis of accounting contemplates the recovery of the Company’s assets and the satisfaction of its liabilities in the normal course of business. Through December 31, 2012, the Company has incurred cumulative losses of $38,617,909 including a net loss for the three months ended December 31, 2012 of $1,057,909. As the Company has limited cash flow from operations, its ability to maintain normal operations is entirely dependent upon obtaining adequate cash to finance its overhead, research and development activities, and acquisition of production equipment. It is unknown when, if ever, the Company will achieve a level of revenues adequate to support its costs and expenses. In order for the Company to meet its basic financial obligations, including salaries, debt service and normal operating expenses, it plans to sell additional units of its water treatment system, and to seek additional equity or debt financing. Because of the Company’s history and current debt levels, there is considerable doubt that the Company will be able to obtain financing. The Company’s ability to meet its cash requirements for the next twelve months depends on its ability to obtain such financing. Even if financing is obtained, any such financing will likely involve additional fees and debt service requirements which may significantly reduce the amount of cash we will have for our operations. Accordingly, there is no assurance that the Company will be able to implement its plans.

11

As mentioned in Notes 5, 6, 7 and 8, the Company has related party notes, convertible notes, and subordinated debentures that have matured. The Company is continuing its efforts to obtain customers for its products, expand its sales efforts worldwide and expand the industries it targets for possible customers. The Company also has future plans for additional products, and revisions to its current products. In support of this the Company plans to hire additional personnel who have the industry experience and the training so that they can be immediately effective in the building of the Company. The Company retains most design, system configuration, and technical engineering resources “in-house.”  Certain design and specific research and development activities are periodically sub-contracted to its partner, Pacific Advanced Civil Engineering, Inc. (“PACE”) as access to scientific and engineering resources exceed Sionix “in-house” capability.  Only fabrication of the DAF component of our DAF system is sub-contracted, and then only for the construction of the stainless steel DAF tank.  With the exception of plumbing and electrical sub-contractors, all other fabrication and assembly activities are supervised and managed by “in-house” resources. This reduces costs and improves the quality of the Company's products. The Company is also continuing to seek additional investment capital in the form of debt or equity to continue operations, and is considering certain changes to its capital structure to become more attractive to potential investors and business partners.

Note 12 – Subsequent Events

Additional 10% Convertible Debentures:

Subsequent to the period ended December 31, 2012 the Company received additional funding of $140,000 in principal amount of 10% Convertible Promissory Notes which have not yet been converted into shares of our common stock.  The notes are convertible at any time at the option of the holders into shares of our common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request, however the conversion price may not exceed $0.04, and may not be lower than $0.02 per share.  Based on the outstanding principal amount of these notes and assuming that interest accrued through September 30, 2014, the due date, the notes would be convertible into approximately 7,000,000 shares of our common stock at a conversion price of $0.02 a share.

Additional 6% Convertible Redeemable Note:

Subsequent to the period ended December 31, 2012 the Company received an advance of $50,000 in principal amount based on the 6% Convertible Redeemable Note agreement.

12

Part I, Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The information in this quarterly report on Form 10-Q contains forward-looking statements.  These forward-looking statements involve risks and uncertainties, including statements regarding our capital needs, business strategy and expectations.  Any statements contained in this report that are not statements of historical facts may be deemed to be forward-looking statements.  In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential” or “continue”, the negative of such terms or other comparable terminology.  Actual events or results may differ materially from those events or results included in the forward-looking statements.  In evaluating these statements, you should consider various factors, including the risks outlined from time to time in the reports we file with the Securities and Exchange Commission.  Some, but not all, of these risks include, among other things:

● our inability to obtain the financing we need to continue our operations;

● changes in regulatory requirements that adversely affect our business;

● loss of our key personnel; and

● risks over which we have no control, such as the general global downturn in the economy which may adversely affect spending by private and government agencies.

We do not intend to update forward-looking statements.  You should refer to and carefully review the information in future documents we file with the Securities and Exchange Commission.

Overview and Plan of Operation

The water treatment recycling and reuse industry is highly fragmented, consisting of many companies involved in various operational capacities, including companies that design fully integrated systems for processing millions of gallons of water for municipal, industrial, and commercial applications. Demand for water treatment and purification has continued to grow due to economic expansion, population growth, scarcity of usable water, concerns about water quality and regulatory requirements.

Many believe the world is facing a global crisis - in both supply and quality. Water is a natural resource that has a limited supply and no true substitute, and yet only a very small percentage of the earth’s water is available for human consumption. Demand for water resources is compounded by a growing and developing world population, Third World urbanization, and increasing water usage in industries such as oil and gas, agriculture and food processing. It has been reported in a television broadcast by CNBC titled “Liquid Assets: The Big Business of Water,” aired originally in 2010, that by 2025, 48 countries will be without sufficient water to meet basic requirements. We believe the lack of water resources is directly linked to inadequate water management strategies on the part of governments, businesses, consumers and private individuals. We expect global water issues will continue to drive both domestic and international demand for water treatment and recycling.

We plan to continue marketing our existing DAF system to potential domestic and international customers. We believe that we are now able to aggressively market our systems to a variety of private companies and governmental entities in several vertical markets including oil and gas, agriculture, manufacturing, health care and public water utilities. We are engaging in selective sales and promotional activities in connection with the operation of the unit, including media exposure. If the unit continues to operate successfully, we believe we can receive orders for operating units.

We are also continuing to consider alternative product designs to accommodate the different needs we are uncovering during our sales efforts. We maintain our relationship with PACE for engineering support.

Recent Developments

In February 2012 we entered into a Water Treatment Agreement with McFall Incorporated, a construction and logistics firm operating in the Williston Basin.  Under the agreement, we agreed to deploy one of our DAF systems to locations in the Williston Basin to decontaminate water emitted from drilling operations.  The agreement had an initial term of 5 years.   Following our execution of the Water Treatment Agreement, we formed Williston Basin I, LLC, a Nevada limited liability company (“WBI”), and in March 2012 we sold 4,000 membership units to 19 accredited investors, raising a total of $1,350,000.  As the holder of 60% of the membership of WBI, we were entitled to 60% of its net profit and distributable assets.  WBI intended to use the proceeds from the offering principally for the acquisition of the assets required for the performance of the Water Treatment Agreement.

13

Upon further review and consideration, we determined that our efforts to treat drilling mud did not allow us to take full advantage of our proprietary DAF system. Accordingly, we have proposed to McFall Incorporated that we amend our existing agreement related to the treatment of drilling mud, and instead direct our efforts in the treatment of fracking water prior to disposal into underground wells.  We have entered into an agreement with an operator of several disposal wells in the Williston Basin and have delivered treatment equipment to the operator’s site in anticipation of treating fracking production water that is currently being delivered to the site, but is too contaminated for disposal into their wells without treatment.  As well, we are developing certain testing and treatment protocols so that our testing activities are properly and accurately aligned with those required and customary in the oil and gas industry.  It is our intention that this project will demonstrate our capabilities in the Williston Basin region.

Related to this change of business focus, on November 26, 2012 we completed the repurchase of all outstanding membership interests in WBI.  In return for their membership interests and the release of WBI from any future claims, we offered the members the option of receiving a pro-rata share of the remaining capital invested into WBI, or they could assign their rights to their remaining capital to Sionix, in return for a convertible note issued by Sionix equal to 100% of their original investment. The pro-rata share calculation did not include our interest in WBI. The cash available for distribution totaled $854,046 or 63.3% of the original investment of $1,350,000. We returned $569,649 of the original capital invested, representing an original investment of $900,000, and issued convertible notes in the amount of $450,000 and received $284,397 of the remaining capital. The convertible notes issued mature on September 30, 2014, bear an annual interest rate of 10% payable in cash or in kind at our election, and are convertible at the election of the holder into common shares of Sionix at a rate of $0.04. As part of this offering, we paid a placement agent a fee of $45,000 for services provided in connection with this offering.

Results of Operations

Three Months Ended December 31, 2012, Compared to Three Months Ended December 31, 2011

Revenues for the three months ended December 31, 2012 and 2011 were $0 and $0, respectively.

The Company’s total operating expenses were $841,493 during the three months ended December 31, 2012, a decrease of $176,351 or 17%, as compared to $1,017,844 for the three months ended December 31, 2011.  General and administrative expenses were $502,864 during the three months ended December 31, 2012, an decrease of $282,757 or 36%, as compared to $785,621 for the three months ended December 31, 2011.  The net decrease in general and administrative expenses was the result of decreases in legal fees and travel costs.. Sales and marketing expenses were $47,716 for the three months ended December 31, 2012, a decrease of $37,709 or 44%, as compared to $85,425 for the three months ended December 31, 2011. The decrease in sales and marketing expense was related to a reduction of personnel and vendors for sales support, as well as decreased travel and related expenses. Research and development expenses were $280,845 during the three months ended December 31, 2012, an increase of $137,553 or 96%, as compared to $143,292 for the three months ended December 31, 2011.

The Company also incurred interest costs related to various notes in the amount of $296,410; an increase of $77,516 from the prior period when it reported interest costs of $218,894. Normal operations were limited by the lack of available cash.

Liquidity and Capital Resources

The Company had cash of $140,235 and $1,348,069 at December 31, 2012 and September 30, 2012, respectively.  Historically the Company’s source of cash for operations has been the sale of its equity and debt securities. During the period ended December 31, 2012 the Company obtained $273,125 from the sale of notes. If it does not receive additional orders or if these orders do not satisfy its capital needs, the Company expects to sell its securities or obtain loans to meet its capital requirements.  The Company has no additional orders for the sale of water treatment systems or for the deployment of its DAF system, except as noted above.  There can be no assurance that sales of the Company’s securities, additional contracts for the sale of water treatment services, or of its water treatment systems, if such sales occur, will provide sufficient capital for its operations or that the Company will not encounter unforeseen difficulties that may deplete its capital resources more rapidly than anticipated.  As of December 31, 2012, approximately $1,983,358 in principal and interest of certain promissory notes issued by the Company were due or will be coming due on or before September 30, 2014, which is the latest maturity date of its existing notes.  The Company can continue normal operations for approximately one month unless additional financing is obtained.

During the three months ended December 31, 2012, the Company used $946,735of cash in operating activities, primarily to fund its net loss. Non-cash adjustments included $215,078 for common stock issued for services, $4,031 for a loss on settlement of debt, $288,037 for the amortization of debt discounts, $14,671 for share based payments to consultants and employees and $10,068 for depreciation. Cash provided by operating activities included $54,073 in accrued expenses. Cash used in operating activities included $100,864 in other current assets, $100,135 in inventory, and $129,760 in account payable.

During the three months ended December 31, 2011, the Company used $620,672 of cash in operating activities. Non-cash adjustments included $3,506 for depreciation, $100,983 for the amortization of beneficial conversion feature and debt discounts, $103,932 for share-based payments to consultants and employees, and $41,911 for a loss on settlement of debt. Cash provided by operating activities included $51,650 in accounts payable. Cash used in operating activities included $16,871 in inventory, $264,661 in other current assets, $398,027 in accrued expenses, and $0 in deferred revenue.

14

Investing Activities

During the three months ended December 31, 2012, the Company acquired property and equipment totaling $5,748 as compared to $0 during the three months ended December 31, 2011. The equipment acquired was mainly for transportation use in the Williston Basin Area.

Financing Activities

During the three months ended December 31, 2012, financing activities provided a loss of $296,522, resulting from cash issued in redemption of subsidiary interests in the amount of $569,647 and $273,125 from borrowings.

During the three months ended December 31, 2011 financing activities provided $641,700, including $150,200 from net proceeds from the sale of common stock and $491,500 from borrowings.

As of December 31, 2012, the Company had an accumulated deficit of $38,617,909. Management anticipates that future operating results will continue to be subject to many of the problems, expenses, delays and risks inherent in the establishment of a developmental business enterprise, many of which the Company cannot control.

Material Trends, Events or Uncertainties

The Company is not certain how the current economic downturn may affect its business.  Because of the global recession, government agencies and private industry may not have the funds to purchase its water treatment systems.  It may also be more difficult for the Company to raise capital in the current economic environment. Other than as discussed herein, the Company does not know of any material trends, events or uncertainties that may impact its operations in the future.

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. This basis of accounting contemplates the recovery of the Company’s assets and the satisfaction of its liabilities in the normal course of business. Through December 31, 2012, the Company has incurred cumulative losses of $38,617,909 including a net loss for the three months ended December 31, 2012 of $1,057,909. As the Company has no cash flow from operations, its ability to maintain normal operations is entirely dependent upon obtaining adequate cash to finance its overhead, research and development activities, and acquisition of production equipment. It is unknown when, if ever, the Company will achieve a level of revenues adequate to support its costs and expenses. In order for the Company to meet its basic financial obligations, including rent, salaries, debt service and operations, it plans to seek additional equity or debt financing. Because of the Company’s history and current debt levels, there is considerable doubt that the Company will be able to obtain financing. The Company’s ability to meet its cash requirements for the next twelve months depends on its ability to obtain such financing. Even if financing is obtained, any such financing will likely involve additional fees and debt service requirements that may significantly reduce the amount of cash it will have for operations. Accordingly, there is no assurance that the Company will be able to implement its plans.

The Company expects to continue to incur substantial operating losses for the foreseeable future, and it cannot predict the extent of the future losses or when it may become profitable, if ever. The Company expects to incur increasing sales and marketing, research and development and general and administrative expenses. Also, the Company has a substantial amount of short-term debt, which will need to be repaid or refinanced, unless it is converted into equity. As a result, if the Company begins to generate revenues from operations, those revenues will need to be significant in order to cover current and anticipated expenses. These factors raise substantial doubt about the Company's ability to continue as a going concern unless it is able to obtain substantial additional financing in the short term and generate revenues over the long term. If the Company is unable to obtain financing, it would likely discontinue its operations.

Critical Accounting Policies

The discussion and analysis of its financial condition and results of operations is based upon the Company’s unaudited condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires it to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an on-going basis, the Company evaluates its critical accounting policies and estimates. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The Company’s critical accounting policies and estimates are discussed in its Annual Report on Form 10-K for the fiscal year ended September 30, 2012.

15

Part I, Item 3.  Quantitative and Qualitative Disclosures about Market Risk.

As a smaller reporting company, the Company is not required to provide this disclosure.

Part I, Item 4.  Controls and Procedures.

(a) Disclosure Controls and Procedures

Regulations under the Securities Exchange Act of 1934 require public companies to maintain “disclosure controls and procedures,” which are defined to mean a company’s controls and other procedures that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

We conducted an evaluation, with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the period covered by this report.  Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of December 31, 2012, our disclosure controls and procedures were effective.

(b) Changes in internal control over financial reporting

During the three months ended December 31, 2012, the Company has not made any changes to internal control over financial reporting that have materially affected, or are reasonably likely to affect, its internal control over financial reporting.

Part II, Item 1.  Legal Proceedings.

On October 24, 2012 our former Chairman and Chief Executive Officer, James. R. Currier, filed in the Superior Court of the State of Arizona in and for the County of Maricopa a legal action against us entitled “James R. Currier v. Sionix Corporation, a Nevada corporation." Mr. Currier's complaint contained claims alleging Breach of Contract, Breach of Implied Covenant of Good Faith and Fair Dealing, Wage Claim, Negligent Misrepresentation and Fraud. The allegations in the complaint related to his resignation from his position as Chief Executive Officer, and from the board as its Chairman and as a member.  The parties have resolved Mr. Currier's claims.

Part II, Item 1A.  Risk Factors.

We incorporate herein by reference the information included in Item 1A. of the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on December 31, 2012.

Part II, Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

During the three months ended December 31, 2012, we:

●      Issued 7,314,379 shares of common stock for services to officers, directors and consultants. We relied on Section 4(2) of the Securities Act of 1933 (the “Act”) in issuing the common stock inasmuch as there was no form of general solicitation or general advertising in the offer and sale of the securities and the officers and directors had access to the information that registration would otherwise provide.

●      Issued 21,738,717 shares of common stock for conversion of debt in the amount of $433,764 (including interest). We relied on Section 3(a)(9) of the Securities Act as providing an exemption from registering the issuance of these shares of common stock inasmuch as the conversion was made with our existing security holders exclusively and no commission or other remuneration was paid or given directly or indirectly for soliciting the exchange.

Part II, Item 3. Defaults Upon Senior Securities

None.

16

Part II, Item 4.  Mine Safety Disclosure.

Not required.

Part II, Item 5.  Other Information.

(a) None.

(b) There were no changes to the procedures by which security holders may recommend nominees to our board of directors.

Part II, Item 6.  Exhibits.

Exhibit No.	Description of Exhibit
3.1	Articles of Incorporation (1)
3.1.1	Amendment to Articles of Incorporation (2)
3.2	Bylaws (1)
31.1	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
101.1	[XBRL Exhibits]

* Filed herewith.

(1) Incorporated by reference from our Current Report on Form 8-K filed with the Securities and Exchange Commission on July 15, 2003 as file number 002-95626-D.

(2) Incorporated by reference from Annex 1 to our definitive proxy statement filed with the Securities and Exchange Commission on February 7, 2010 as file number 002-95626-D.

17

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: February 19, 2013

SIONIX CORPORATION

/s/ Kenneth Calligar

Kenneth Calligar

Interim Chief Executive Officer (Principal Executive Officer)

/s/ David R. Wells

David R. Wells

President, Chief Financial Officer, Secretary/Treasurer, and Principal Financial and Accounting Officer

18

EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULE 13A-14

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

(SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002)

I, Kenneth Calligar, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Sionix Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 19, 2013

/s/ Kenneth Calligar

Kenneth Calligar

Interim Chief Executive Officer, and Principal Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO RULE 13A-14

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

(SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002)

I, David R. Wells, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Sionix Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 19, 2013

/s/ David R. Wells

David R. Wells

President, Chief Financial Officer, Secretary/Treasurer, and Principal Financial and Accounting Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 (AS ADOPTED

PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002)

In connection with the Quarterly Report of Sionix Corporation (the “Company”) on Form 10-Q for the period ended December 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kenneth Calligar, Chief Executive Officer of the Company, certify to my knowledge and in my capacity as an officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and,
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

Date: February 19, 2013

/s/ Kenneth Calligar

Kenneth Calligar

Interim Chief Executive Officer, and Principal Executive Officer

A certification furnished pursuant to this Item will not be deemed “filed” for purposes of section 18 of the Exchange Act (15 U.S.C. 78r), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 (AS ADOPTED

PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002)

In connection with Quarterly Report of Sionix Corporation (the “Company”) on Form 10-Q for the period ended December 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David R. Wells, Chief Financial Officer of the Company, certify to my knowledge and in my capacity as an officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and,
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

Date: February 19, 2013

/s/ David R. Wells

David R. Wells

President, Chief Financial Officer, Secretary/Treasurer, and Principal Financial and Accounting Officer

A certification furnished pursuant to this Item will not be deemed “filed” for purposes of section 18 of the Exchange Act (15 U.S.C. 78r), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

XML

Stockholders' Equity (Details 3) (Warrant [Member], USD $)	3 Months Ended
	Dec. 31, 2012
Schedule of options/warrants outstanding and exercisable
Options/Warrants Outstanding	110,861,903
Options/Warrants Exercisable	110,861,903
$ 0.06 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.06
Options/Warrants Outstanding	7,500,000
Options/Warrants Exercisable	7,500,000
Options/Warrants Contractual Life	3 years 4 months 16 days
Weighted Average Exercise Price Outstanding	$ 0.06
Weighted Average Exercise Price Exercisable	$ 0.06
$ 0.07 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.07
Options/Warrants Outstanding	22,833,333
Options/Warrants Exercisable	22,833,333
Options/Warrants Contractual Life	1 year 3 months 14 days
Weighted Average Exercise Price Outstanding	$ 0.07
Weighted Average Exercise Price Exercisable	$ 0.07
$ 0.08 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.08
Options/Warrants Outstanding	25,425,000
Options/Warrants Exercisable	25,425,000
Options/Warrants Contractual Life	4 years 8 months 22 days
Weighted Average Exercise Price Outstanding	$ 0.08
Weighted Average Exercise Price Exercisable	$ 0.08
$ 0.10 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.10
Options/Warrants Outstanding	6,726,578
Options/Warrants Exercisable	6,726,578
Options/Warrants Contractual Life	3 years 1 month 9 days
Weighted Average Exercise Price Outstanding	$ 0.10
Weighted Average Exercise Price Exercisable	$ 0.10
$ 0.12 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.12
Options/Warrants Outstanding	6,226,000
Options/Warrants Exercisable	6,226,000
Options/Warrants Contractual Life	10 months 24 days
Weighted Average Exercise Price Outstanding	$ 0.12
Weighted Average Exercise Price Exercisable	$ 0.12
$ 0.14 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.14
Options/Warrants Outstanding	5,000,000
Options/Warrants Exercisable	5,000,000
Options/Warrants Contractual Life	2 years 9 months 21 days
Weighted Average Exercise Price Outstanding	$ 0.14
Weighted Average Exercise Price Exercisable	$ 0.14
$ 0.15 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.15
Options/Warrants Outstanding	2,107,667
Options/Warrants Exercisable	2,107,667
Options/Warrants Contractual Life	1 year 9 months 28 days
Weighted Average Exercise Price Outstanding	$ 0.15
Weighted Average Exercise Price Exercisable	$ 0.15
$ 0.17 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.17
Options/Warrants Outstanding	27,993,325
Options/Warrants Exercisable	27,993,325
Options/Warrants Contractual Life	2 years 10 months 24 days
Weighted Average Exercise Price Outstanding	$ 0.17
Weighted Average Exercise Price Exercisable	$ 0.17
$ 0.18 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.18
Options/Warrants Outstanding	850,000
Options/Warrants Exercisable	850,000
Options/Warrants Contractual Life	1 day
Weighted Average Exercise Price Outstanding	$ 0.18
Weighted Average Exercise Price Exercisable	$ 0.18
$ 0.25 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.25
Options/Warrants Outstanding	3,700,000
Options/Warrants Exercisable	3,700,000
Options/Warrants Contractual Life	1 year 2 months 12 days
Weighted Average Exercise Price Outstanding	$ 0.25
Weighted Average Exercise Price Exercisable	$ 0.25
$ 0.30 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	$ 0.30
Options/Warrants Outstanding	2,500,000
Options/Warrants Exercisable	2,500,000
Options/Warrants Contractual Life	4 months 24 days
Weighted Average Exercise Price Outstanding	$ 0.30
Weighted Average Exercise Price Exercisable	$ 0.30

XML

Accrued Expenses (Details Textual) (USD $)	3 Months Ended
	Dec. 31, 2012
Accrued Expenses (Textual)
Debt conversion, accrued interest converted into stock	$ 13,032

XML

Accrued Expenses

3 Months Ended

Dec. 31, 2012

Accrued Expenses [Abstract]

Accrued Expenses

Note 4 – Accrued Expenses

Accrued expenses consisted of the following at:

	December 31, 2012		September 30, 2012
Accrued salaries	$	281,752	$	306,055
Interest payable		415,876		364,567
Other accrued expenses		247,105		237,106
Total accrued expenses	$	944,733	$	907,728

During the three months ended December 31, 2012, $13,032 of accrued interest was included in the conversion of notes payable into common stock described in Note 6.

XML

Long Term Debt (Details) (USD $)	3 Months Ended		1 Months Ended
	Dec. 31, 2012	Sep. 30, 2012	Nov. 30, 2012 10% Convertible Debt (WBI) [Member]	Nov. 26, 2012 10% Convertible Debt (WBI) [Member]
Long Tem Debt (Textual)
Description of consideration offered by company for repurchase of outstanding membership interest in WBI			Company offered the members the option of receiving a pro-rata share of the remaining capital invested into WBI, or they could assign their rights to their remaining capital to Sionix in return for a convertible note issued by Sionix equal to 100% of their original investment.
Amount of cash available for cash distribution			$ 854,046
Percentage of distribution on original investment			63.30%
Amount of original investment			1,350,000
Amount of original investment returned			569,649
Decreased amount of original investment			900,000
Convertible notes payable	1,983,358	1,895,378		450,000
Remaining capital of original investment			284,397
Additional capital received from issuance of additional notes			250,000
Amount of additional note issued				394,000
Debt discount				144,000
Convertible notes maturity date	Sep. 30, 2014		Sep. 30, 2014
Interest rate on convertible note			10.00%
Convertible notes conversion price				$ 0.04
Payment of placement agent fees			$ 45,000

XML

12% Secured Promissory Note (Details) (USD $)	3 Months Ended		1 Months Ended
	Dec. 31, 2012	Sep. 30, 2012	Nov. 30, 2011 12% Secured Promissory Note [Member]	Nov. 08, 2011 12% Secured Promissory Note [Member]
12% Secured Promissory Note (Textual)
Interest rate on secured promissory note				12.00%
Secured promissory notes	$ 64,027	$ 225,681		$ 300,000
Maturity date of secured promissory note	Sep. 30, 2014		Jul. 31, 2012
Debt instrument percentage of redemption premium				7.50%
Stock issued during the period as incentive shares				2,358,491
Stock issued during the period as pledged shares				16,981,132
Redemption amount of incentive shares				$ 125,000

XML

Stockholders' Equity (Details) (Employee Stock Options and Warrants [Member], USD $)	3 Months Ended	12 Months Ended
	Dec. 31, 2012	Sep. 30, 2012
Employee Stock Options and Warrants [Member]
Summary of the Company's activity for employee stock options/ stock warrants
Outstanding options/warrant, Beginning balance	43,716,316
Granted option	500,000
Expired option	(3,933,526)
Forfeited option	(500,000)
Exercised option
Outstanding options/warrants, Ending balance	39,782,790	43,716,316
Outstanding options/warrants exercisable	39,782,790
Outstanding options, Weighted Average Exercise Price, Beginning balance	$ 0.12
Granted, Weighted Average Exercise Price	$ 0.15
Expired, Weighted Average Exercise Price	$ 0.21
Forfeited, Weighted Average Exercise Price	$ 0.15
Exercised, Weighted Average Exercise Price
Outstanding options/warrants, Weighted Average Exercise Price, Ending balance	$ 0.11	$ 0.12
Outstanding options/warrants exercisable, Weighted Average Exercise Price	$ 0.11
Outstanding options/warrants, Aggregate Intrinsic Value
Outstanding options/warrants, Granted, Aggregate Intrinsic Value
Outstanding options/warrants, Expired, Aggregate Intrinsic Value
Outstanding options/warrants, Forfeited , Aggregate Intrinsic Value
Outstanding options/warrants, Exercised, Aggregate Intrinsic Value
Outstanding options/warrants, Aggregate Intrinsic Value
Outstanding options/warrants exercisable, Aggregate Intrinsic Value
Outstanding options, Weighted Average Remaining Contractual Life	2 years 2 months 19 days	3 years 4 days
Granted options, Weighted Average Remaining Contractual Life	4 years 9 months
Outstanding options exercisable, Weighted Average Remaining Contractual Life	2 years 2 months 16 days

XML

Stockholders' Equity (Details 1) (Employee Stock Options and Warrants [Member], USD $)	3 Months Ended
	Dec. 31, 2012
Schedule of options/warrants outstanding and exercisable
Options/Warrants Outstanding	39,782,790
Options/Warrants Contractual Life	2 years 2 months 19 days
Options/Warrants Exercisable	39,392,406
Weighted Average Remaining Contractual Life	2 years 2 months 16 days
$ 0.06 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.06
Options/Warrants Outstanding	7,415,000
Options/Warrants Contractual Life	2 years 8 months 5 days
Options/Warrants Exercisable	7,366,260
Weighted Average Remaining Contractual Life	2 years 7 months 28 days
$ 0.07 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.07
Options/Warrants Outstanding	2,000,000
Options/Warrants Contractual Life	3 years
Options/Warrants Exercisable	2,000,000
Weighted Average Remaining Contractual Life	3 years
$ 0.09 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.09
Options/Warrants Outstanding	2,000,000
Options/Warrants Contractual Life	3 years
Options/Warrants Exercisable	2,000,000
Weighted Average Remaining Contractual Life	3 years
$ 0.10 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.10
Options/Warrants Outstanding	8,416,850
Options/Warrants Contractual Life	1 year 9 months 4 days
Options/Warrants Exercisable	8,416,850
Weighted Average Remaining Contractual Life	1 year 9 months 4 days
$ 0.12 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.12
Options/Warrants Outstanding	8,450,940
Options/Warrants Contractual Life	1 year 3 months 11 days
Options/Warrants Exercisable	8,450,940
Weighted Average Remaining Contractual Life	1 year 3 months 11 days
$ 0.14 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.14
Options/Warrants Outstanding	500,000
Options/Warrants Contractual Life	3 years 5 months 1 day
Options/Warrants Exercisable	158,356
Weighted Average Remaining Contractual Life	1 year 29 days
$ 0.15 [Member]
Schedule of options/warrants outstanding and exercisable
Options/Warrants Exercise price	0.15
Options/Warrants Outstanding	11,000,000
Options/Warrants Contractual Life	2 years 7 months 28 days
Options/Warrants Exercisable	11,000,000
Weighted Average Remaining Contractual Life	2 years 7 months 28 days

XML

Property and Equipment

3 Months Ended

Dec. 31, 2012

Property and Equipment [Abstract]

Property and Equipment

Note 3 – Property and Equipment

Property and equipment consisted of the following at:

	December 31, 2012			September 30, 2012
Machinery and equipment	$	128,509		$	166,159
Less accumulated depreciation		(48,109	)		(38,040	)
Property and equipment, net	$	80,400		$	128,119

Depreciation expense for the three months ended December 31, 2012 and 2011 was $10,068 and $3,506, respectively.

XML

Stockholders' Equity (Details 2) (Warrant [Member], USD $)	3 Months Ended
	Dec. 31, 2012
Warrant [Member]
Summary of the Company's activity for employee stock options/ stock warrants
Outstanding options/warrant, Beginning balance	114,460,085
Granted warrants	625,000
Expired warrants	(4,223,182)
Forfeited warrants
Exercised warrants
Outstanding options/warrants, Ending balance	110,861,903
Outstanding options/warrants exercisable	110,861,903
Outstanding options, Weighted Average Exercise Price, Beginning balance	$ 0.12
Granted, Weighted Average Exercise Price	$ 0.08
Expired, Weighted Average Exercise Price	$ 0.26
Forfeited, Weighted Average Exercise Price
Exercised, Weighted Average Exercise Price
Outstanding options/warrants, Weighted Average Exercise Price, Ending balance	$ 0.13
Outstanding options/warrants exercisable, Weighted Average Exercise Price	$ 0.12
Outstanding options/warrants, Aggregate Intrinsic Value	$ 75,000
Outstanding options/warrants, Granted, Aggregate Intrinsic Value
Outstanding options/warrants, Expired, Aggregate Intrinsic Value
Outstanding options/warrants, Forfeited , Aggregate Intrinsic Value
Outstanding options/warrants, Exercised, Aggregate Intrinsic Value
Outstanding options/warrants, Aggregate Intrinsic Value	75,000
Outstanding options/warrants exercisable, Aggregate Intrinsic Value	$ 75,000

XML

Condensed Consolidated Balance Sheets (USD $)	Dec. 31, 2012	Sep. 30, 2012
Current assets:
Cash and cash equivalents	$ 140,235	$ 1,348,069
Other receivable	11,496	27,854
Inventory	1,411,484	1,311,349
Other current assets	165,785	91,529
Total current assets	1,729,000	2,778,801
Non-current assets:
Property and equipment, net	80,400	128,119
Total assets	1,809,400	2,906,920
Current liabilities:
Accounts payable	113,369	155,547
Accrued expenses	944,733	907,728
Notes payable - related parties	25,000	25,000
Convertible notes, net of debt discount	1,983,358	1,895,378
Secured promissory notes	64,027	225,681
Deferred Revenue	10,000	10,000
Derivative liability	420,028	638,178
Shares to be issued	68,184	165,880
Total current liabilities	3,628,699	4,023,392
Long-Term Debt, net of discount	700,000
Total Liabilities	4,328,699	4,023,392
Stockholders' Deficit Attributable to Sionix Corporation:
Preferred stock, $0.001 par value, 10,000,000 shares authorized at December 31, 2012
Common stock, $0.001 par value (600,000,000 shares authorized; 417,021,530 shares issued and outstanding at December 31, 2012; 387,968,434 shares issued and outstanding at September 30, 2012)	417,022	387,968
Additional paid-in capital	35,681,588	34,807,672
Accumulated deficit	(38,617,909)	(37,560,000)
Total stockholders' deficit attributable to Sionix Corporation	(2,519,299)	(2,364,360)
Equity attributable to noncontrolling interest		1,247,888
Total stockholders' deficit	(2,519,299)	(1,116,472)
Total liabilities and stockholders' deficit	$ 1,809,400	$ 2,906,920

XML

Organization and Description of Business

3 Months Ended

Dec. 31, 2012

Organization and Description Of Business [Abstract]

Organization and Description of Business

Note 1 – Organization and Description of Business

Sionix Corporation (the "Company") was incorporated in Utah in 1996.  The Company completed its reincorporation as a Nevada corporation effective July 1, 2003. Sionix designs, develops, markets and sells cost-effective water management and treatment solutions intended for use in the oil and gas, agriculture, industrial, disaster relief, and municipal (both potable and wastewater) markets. The Company’s Mobile Water Treatment System contains a Dissolved Air Floatation (“DAF”) system with patented technology that management estimates removes more than 99% of the organic, and most inorganic, particles in water.  Historically, DAF systems created bubbles that were 50+ microns in size, which were unable to remove all contaminants due to their size. The Sionix system utilizes and refines DAF technology to provide a pre-treatment process using ambient oxygen and minimal chemical flocculent aids that the Company believes is efficient and cost-effective. The patented Sionix technology makes micro-bubbles which allow a greater percentage of contaminants to be captured, floated to the surface and skimmed off, without harmful chemicals.

XML

Going Concern (Details) (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Sep. 30, 2012
Going Concern (Textual)
Accumulated deficit	$ (38,617,909)		$ (37,560,000)
Net loss	$ (1,057,909)	$ (1,194,502)

XML

Property and Equipment (Details) (USD $)	Dec. 31, 2012	Sep. 30, 2012
Components of Property and equipment
Machinery and equipment	$ 128,509	$ 166,159
Less accumulated depreciation	(48,109)	(38,040)
Property and equipment, net	$ 80,400	$ 128,119

XML

Subsequent Events (Details) (USD $)	3 Months Ended		2 Months Ended	12 Months Ended						1 Months Ended		3 Months Ended
	Dec. 31, 2012 Minimum [Member]	Dec. 31, 2012 Maximum [Member]	Feb. 19, 2013 10% Convertible Debentures	Sep. 30, 2012 10% Convertible Debentures	Nov. 26, 2012 10% Convertible Debentures	Feb. 19, 2013 10% Convertible Debentures Minimum [Member]	Sep. 30, 2012 10% Convertible Debentures Minimum [Member]	Feb. 19, 2013 10% Convertible Debentures Maximum [Member]	Sep. 30, 2012 10% Convertible Debentures Maximum [Member]	Sep. 30, 2012 6% Convertible Redeemable Note	Nov. 30, 2011 6% Convertible Redeemable Note	Dec. 31, 2012 6% Convertible Redeemable Note	Feb. 19, 2013 6% Convertible Redeemable Note	Sep. 21, 2012 6% Convertible Redeemable Note	Nov. 23, 2011 6% Convertible Redeemable Note
Subsequent Events (Textual)
Interest rate on secured promissory note			10.00%										6.00%	6.00%	6.00%
Convertible promissory note, principal amount			$ 140,000											$ 100,000	$ 100,000
Convertible debt, terms of conversion			The notes are convertible at any time at the option of the holders into shares of our common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request.	The Notes are convertible at any time at the option of the Holders into the Company's common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request.						The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.	The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.
Convertible notes conversion price	$ 0.02	$ 0.15	$ 0.02		$ 0.04	$ 0.02	$ 0.02	$ 0.04	$ 0.04						$ 0.001
Convertible notes, share issuable upon conversion			7,000,000
Advance received on convertible note													$ 50,000
Interest rate on convertible note	6.00%	12.00%		10.00%								6.00%

XML

Accrued Expenses (Details) (USD $)	Dec. 31, 2012	Sep. 30, 2012
Components of Accrued expenses
Accrued salaries	$ 281,752	$ 306,055
Interest payable	415,876	364,567
Other accrued expenses	247,105	237,106
Total accrued expenses	$ 944,733	$ 907,728

XML

Basis of Presentation and Summary of Significant Accounting Policies

3 Months Ended

Dec. 31, 2012

Basis Of Presentation and Summary Of Significant Accounting Policies [Abstract]

Basis of Presentation and Summary of Significant Accounting Policies

Note 2 – Basis of Presentation and Summary of Significant Accounting Policies

In the opinion of management, the accompanying balance sheets and related interim statements of operations, and cash flows include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s annual report on Form 10-K for the fiscal year ended September 30, 2012 filed with the U.S. Securities and Exchange Commission (the “Commission”) on December 31, 2012.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  Significant estimates include collectability of accounts receivable, accounts payable, sales returns, and recoverability of long-term assets.

Consolidation

All significant intercompany accounts and balances have been eliminated in consolidation. Participation of other unit holders in the net assets and net earnings of consolidated subsidiaries is included in the captions ‘equity attributable to noncontrolling interest’ and ‘net loss attributable to the noncontrolling interest’ in the accompanying condensed consolidated balance sheet and condensed consolidated statement of operations, respectively.

Recently Issued Accounting Pronouncements

In December 2011, the FASB issued disclosure guidance related to the offsetting of assets and liabilities. The guidance requires an entity to disclose information about offsetting and related arrangements for recognized financial and derivative instruments to enable users of its financial statements to understand the effect of those arrangements on its financial position. The amended guidance is effective for us on a retrospective basis commencing in the first quarter of 2014. We are currently evaluating the impact of this new guidance on our consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-08, “Intangibles – Goodwill and Other (Topic 350): Testing Goodwill for Impairment.” ASU No. 2011-08 provides companies an option to perform a qualitative assessment to determine whether further goodwill impairment testing is necessary. If, as a result of the qualitative assessment, it is determined that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, the two-step quantitative impairment test is required. Otherwise, no further testing is required. ASU No. 2011-08 will be effective for the Company for goodwill impairment tests performed in the fiscal year ending September 30, 2013, with early adoption permitted. The adoption of this guidance is expected to have no impact on the Company’s consolidated financial condition and results of operations.

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220): Presentation of Comprehensive Income.” ASU No. 2011-05 eliminates the option to present components of other comprehensive income as part of the statement of shareholders’ equity. All non-owner changes in shareholders’ equity instead must be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Also, reclassification adjustments for items that are reclassified from other comprehensive income to net income must be presented on the face of the financial statements. ASU No. 2011-05 was effective for the Company for the quarter ending December 31, 2012. The adoption of this guidance had no impact on the Company’s financial condition and results of operations.

In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs.” ASU No. 2011-04 clarifies and changes the application of various fair value measurement principles and disclosure requirements, and was effective for the Company in the second quarter of fiscal 2012 (January 1, 2012). The adoption of this guidance had no impact on the Company’s consolidated financial condition and results of operations.

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2012	Sep. 30, 2012
Balance Sheets [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	600,000,000	600,000,000
Common stock, shares issued	417,021,530	387,968,434
Common stock, shares outstanding	417,021,530	387,968,434

XML

Subsequent Events

3 Months Ended

Dec. 31, 2012

Subsequent Events [Abstract]

Subsequent Events

Note 12 – Subsequent Events

Additional 10% Convertible Debentures:

Subsequent to the period ended December 31, 2012 the Company received additional funding of $140,000 in principal amount of 10% Convertible Promissory Notes which have not yet been converted into shares of our common stock.  The notes are convertible at any time at the option of the holders into shares of our common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request, however the conversion price may not exceed $0.04, and may not be lower than $0.02 per share.  Based on the outstanding principal amount of these notes and assuming that interest accrued through September 30, 2014, the due date, the notes would be convertible into approximately 7,000,000 shares of our common stock at a conversion price of $0.02 a share.

Additional 6% Convertible Redeemable Note:

Subsequent to the period ended December 31, 2012 the Company received an advance of $50,000 in principal amount based on the 6% Convertible Redeemable Note agreement.

XML

Document and Entity Information	3 Months Ended
	Dec. 31, 2012	Feb. 15, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	SIONIX CORP
Entity Central Index Key	0000764667
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Document Type	10-Q
Document Period End Date	Dec. 31, 2012
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q1
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		426,996,914

XML

Basis of Presentation and Summary of Significant Accounting Policies (Policies)

3 Months Ended

Dec. 31, 2012

Basis Of Presentation and Summary Of Significant Accounting Policies [Abstract]

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  Significant estimates include collectability of accounts receivable, accounts payable, sales returns, and recoverability of long-term assets.

Consolidation

Consolidation

All significant intercompany accounts and balances have been eliminated in consolidation. Participation of other unit holders in the net assets and net earnings of consolidated subsidiaries is included in the captions ‘equity attributable to noncontrolling interest’ and ‘net loss attributable to the noncontrolling interest’ in the accompanying condensed consolidated balance sheet and condensed consolidated statement of operations, respectively.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

In December 2011, the FASB issued disclosure guidance related to the offsetting of assets and liabilities. The guidance requires an entity to disclose information about offsetting and related arrangements for recognized financial and derivative instruments to enable users of its financial statements to understand the effect of those arrangements on its financial position. The amended guidance is effective for us on a retrospective basis commencing in the first quarter of 2014. We are currently evaluating the impact of this new guidance on our consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-08, “Intangibles – Goodwill and Other (Topic 350): Testing Goodwill for Impairment.” ASU No. 2011-08 provides companies an option to perform a qualitative assessment to determine whether further goodwill impairment testing is necessary. If, as a result of the qualitative assessment, it is determined that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, the two-step quantitative impairment test is required. Otherwise, no further testing is required. ASU No. 2011-08 will be effective for the Company for goodwill impairment tests performed in the fiscal year ending September 30, 2013, with early adoption permitted. The adoption of this guidance is expected to have no impact on the Company’s consolidated financial condition and results of operations.

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220): Presentation of Comprehensive Income.” ASU No. 2011-05 eliminates the option to present components of other comprehensive income as part of the statement of shareholders’ equity. All non-owner changes in shareholders’ equity instead must be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Also, reclassification adjustments for items that are reclassified from other comprehensive income to net income must be presented on the face of the financial statements. ASU No. 2011-05 was effective for the Company for the quarter ending December 31, 2012. The adoption of this guidance had no impact on the Company’s financial condition and results of operations.

In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs.” ASU No. 2011-04 clarifies and changes the application of various fair value measurement principles and disclosure requirements, and was effective for the Company in the second quarter of fiscal 2012 (January 1, 2012). The adoption of this guidance had no impact on the Company’s consolidated financial condition and results of operations.

XML

Condensed Consolidated Statement of Operations (Unaudited) (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Operating expenses
General and administrative	$ 502,864	$ 785,621
Sales and marketing	47,716	85,425
Research and development	280,845	143,292
Depreciation	10,068	3,506
Total operating expenses	841,493	1,017,844
Loss from operations	(841,493)	(1,017,844)
Other income (expense)
Interest expense and financing costs	(296,410)	(218,894)
Gain (loss) on change in fair value of derivative liability	78,191	325
Loss on sale of property and equipment	(2,228)
Gain on settlement of debt	4,031	41,911
Total other income (expense)	(216,416)	(176,658)
Loss before income taxes	(1,057,909)	(1,194,502)
Income taxes
Net loss	$ (1,057,909)	$ (1,194,502)
Basic loss per share	$ 0.00	$ 0.00
Diluted loss per share	$ 0.00	$ 0.00
Basic weighted average number of shares of common stock outstanding	399,961,376	304,868,562
Diluted weighted average number of shares of common stock outstanding	399,961,376	304,868,562

XML

12% Secured Promissory Note

3 Months Ended

Dec. 31, 2012

Convertible Notes, 12 Secured Promissory Note and Long Term Debt [Abstract]

12% Secured Promissory Note

Note 7 – 12% Secured Promissory Note

On November 8, 2011 Sionix issued a 12% Secured Promissory Note in the principal amount of $300,000 maturing on July 31, 2012. The Company had an optional right of redemption prior to maturity. Sionix was to redeem the debenture on the maturity date at a redemption premium of 7.5%. Sionix granted to the investor a continuing, first priority security interest in certain property of Sionix to secure the prompt payment, performance, and discharge in full of all of the Company’s obligations under the Secured Promissory Note, Securities Purchase Agreement, and Pledge Agreement.

In connection with this borrowing, Sionix issued 2,358,491 shares of common stock as Incentive Shares, and 16,981,132 shares of common stock as Pledged Shares. At the Company’s option, the Incentive Shares may be redeemed for cash in the amount of $125,000; otherwise they are retained by the lender. The value of the Incentive Shares has been classified as a liability and is being amortized as interest expense over the term of the borrowing. The Pledged Shares were issued as security under the Pledge Agreement.

The Company is continuing to issue shares to reduce the outstanding balance, and no default based on the elapsed maturity date has been declared by the note holder.  After conversions, the amount outstanding as of December 31, 2012 amounted to $64,027.

XML

Convertible Notes

3 Months Ended

Dec. 31, 2012

Convertible Notes, 12 Secured Promissory Note and Long Term Debt [Abstract]

Convertible Notes

Note 6 – Convertible Notes

At December 31, 2012 and September 30, 2012, convertible notes payable amounted to $1,983,358 and $1,895,378, respectively, net of discounts of $344,464 and $383,600 respectively. The notes bear interest at 6% - 12% per annum, and are convertible into common stock of the Company at $0.02 - $0.15 per share (as well as variable conversion rates as described below). The notes are due at various dates through September 2014 and are unsecured.

Unsecured Convertible Notes:

Through December 31, 2012, the Company issued $700,000 of convertible debentures (of which $87,500 is outstanding at December 31, 2012) that are convertible into common stock of the Company at variable conversion rates that provide a fixed rate of return to the note-holder. Under the terms of the notes, however, the Company could be required to issue additional shares of common stock in the event of default. The Company applied the provisions of ASC Topic 815, “Derivatives and Hedging” and determined that the conversion option should be bifurcated from the notes and valued separately. This conversion option has been recorded as a derivative liability, is being amortized over the terms of the related notes, and is carried at fair value in the accompanying balance sheet. During the three months ended December 31, 2012 and 2011, the change in fair value of this derivative liability amounted to $78,191 and $325, respectively.

During the three months ended December 31, 2012, holders of convertible debentures elected to convert $82,500 of their debt plus accrued interest into 8,569,317 shares of common stock.

6% Convertible Redeemable Note:

On November 23, 2011 Sionix issued a 6% Convertible Redeemable Note in the principal amount $100,000 maturing on November 23, 2012. In addition, the Company received a commitment in the form of a promissory note from the lender pursuant to which the lender provided the Company with funding of up to an additional $300,000 beginning on June 1, 2012, at which time $100,000 became available, on each of June 1, 2012, July 1, 2012 and August 1, 2012 (the "Additional Financing"). All funds were advanced as agreed for a total of $400,000. Sionix paid fees of $45,000 in connection with the funding of these loans. The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.

For the period ending December 31, 2012 there was $36,600 outstanding on these Notes.

On September 21, 2012 Sionix issued a 6% Convertible Redeemable Note in the principal amount $100,000 to GEL Properties.  The note matures on September 21, 2013.  The Company has an optional right of redemption prior to maturity upon a five-day notice and payment of a 50% premium on the unpaid principal amount of the loan.  The Company paid fees of $6,000 in connection with the funding of this loan. In addition, the Company received a commitment in the form of a promissory note from GEL Properties pursuant to which it will provide Sionix with funding of an additional $300,000, $100,000 of which will become available on each of July 1, 2013, August 15, 2013 and October 1, 2013.  The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.

For the period ending December 31, 2012 there was $100,000 outstanding on these Notes.

10% Convertible Debentures:

On September 29, 2012 the Company entered into a securities purchase agreement dated September 25, 2012 with several accredited investors (“Holders”) for the purchase and sale of $1,025,000 of its convertible notes (“Notes”) and warrants.    The Notes bear interest at the rate of 10% per annum beginning as of September 25, 2012, and mature on June 25, 2013.  On the closing date, the Company paid and the Holders received nine months of pre-paid interest on the original principal amount of the Notes (based on the agreed nine-month term of the Notes).

The Notes are convertible at any time at the option of the Holders into the Company’s common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request, however the conversion price may not exceed $0.04, and may not be lower than $0.02 per share.  The Notes may be redeemed by the Company at any time prior to maturity with ten days’ prior notice to the Holders, and payment of a premium of 25% on the unpaid principal amount of the Notes.  In addition the Notes and related securities purchase agreement contain representations, warranties and covenants that are customary for financings of this type.

The Company issued warrants to the Holders for the purchase of up to 23,125,000 shares of Company common stock, pro rata in proportion to the amount invested, which can be exercised for a period of five years from the closing date, with a fixed exercise price of $0.08 per share.

The Company agreed to register the common stock into which the Notes may be converted, any shares of common stock that may be issued as payment of principal or interest, and the common stock underlying the warrants, as well as any shares of common stock that may be issued as a result of any stock split, dividend or other distribution. The Company agreed to file an initial registration statement within 30 days of the date of the registration rights agreement.  If the Company fails to file a registration statement within this 30 day period, or to have it declared effective within 90 days after the date of the registration rights agreement, or to maintain its effectiveness (in addition to other events described in the full text of the registration rights agreement), the Company will be obligated to pay the investors liquidated damages equal to 2% of the principal amount of the Notes per month until the event is cured, for up to one year, and 1% per month thereafter if the event continues uncured

The offering was made with the services of a placement agent.  At the closing of the sale and issuance of the Notes, the Company paid a cash fee to the placement agent in the amount of $87,535 or 8.54% of the gross proceeds of the offering.

XML

Property and Equipment (Details Textual) (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Property and Equipment (Textual)
Depreciation expense	$ 10,068	$ 3,506

XML

Property and Equipment (Tables)

3 Months Ended

Dec. 31, 2012

Property and Equipment [Abstract]

Components of Property and equipment

	December 31, 2012			September 30, 2012
Machinery and equipment	$	128,509		$	166,159
Less accumulated depreciation		(48,109	)		(38,040	)
Property and equipment, net	$	80,400		$	128,119

XML

Stockholders' Equity

3 Months Ended

Dec. 31, 2012

Stockholders' Equity [Abstract]

Stockholders' Equity

Note 10 – Stockholders’ Equity

Common Stock

The Company has 600,000,000 authorized shares of common stock, par value $0.001 per share. As of December 31, 2012, the Company had 417,021,530 shares issued and outstanding. As of September 30, 2012, the Company had 387,968,434 shares of common stock issued and outstanding.

During the three months ended December 31, 2012, the Company issued 7,314,379 shares of common stock for services to officers, directors and consultants (valued at $215,078) based on closing market prices. The Company also issued 21,738,717 shares of common stock for conversion of debt in the amount of $433,764 (including interest).

Employee Stock Options and Warrants

A summary of the Company’s activity for employee stock options and warrants:

	Number of Options			Weighted  Average  Exercise Price		Aggregate Intrinsic Value		Weighted  Average  Remaining  Contractual Life
Outstanding at October 1, 2012		43,716,316		$	0.12	$	-		3.01
Granted		500,000			0.15		-		4.75
Expired		(3,933,526	)		0.21		-		-
Forfeited		(500,000	)		0.15		-		-
Exercised		-			-		-		-
Outstanding at December 31, 2012		39,782,790			0.11		-		2.22
Exercisable at December 31, 2012		39,782,790		$	0.11	$	-		2.21

Outstanding and exercisable as of December 31, 2012:

	Exercise Price	Options Outstanding		Contractual Life		Weighted Average Remaining Options Exercisable		Weighted Average Remaining Contractual Life
$	0.06		7,415,000		2.68		7,366,260		2.66
$	0.07		2,000,000		3.00		2,000,000		3.00
$	0.09		2,000,000		3.00		2,000,000		3.00
$	0.10		8,416,850		1.76		8,416,850		1.76
$	0.12		8,450,940		1.28		8,450,940		1.28
$	0.14		500,000		3.42		158,356		1.08
$	0.15		11,000,000		2.66		11,000,000		2.66
			39,782,790		2.22		39,392,406		2.21

During the three months ended December 31, 2012, the Company granted a total of 500,000 options and warrants to certain officers and employees. The options and warrants vested immediately upon grant and have a term of five years. The weighted average grant-date fair value of these options and warrants was $14,671.   The fair value of these options and warrants was estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

● risk free rate of return of 0.72%;

● volatility of 171%

● dividend yield of 0%; and

● expected term of 5 years.

Stock Warrants

A summary of the Company’s warrant activity with non-employees:

	Number of Warrants			Weighted  Average  Exercise Price		Aggregate Intrinsic Value
Outstanding at October 1, 2012		114,460,085		$	0.12	$	75,000
Granted		625,000			0.08		-
Expired		(4,223,182	)		0.26		-
Forfeited		-			-		-
Exercised		-			-		-
Outstanding as of December 31, 2012		110,861,903		$	0.13	$	75,000
Exercisable as of December 31, 2012		110,861,903		$	0.12	$	75,000

Warrants outstanding and exercisable as of December 31, 2012:

						Weighted
						Average
						Remaining		Weighted Average
	Exercise	Warrants		Warrants		Contractual		Exercise Price
	Price	Outstanding		Exercisable		Life		Outstanding		Exercisable
$	0.06		7,500,000		7,500,000		3.38	$	0.06	$	0.06
$	0.07		22,833,333		22,833,333		1.29	$	0.07	$	0.07
$	0.08		25,425,000		25,425,000		4.73	$	0.08	$	0.08
$	0.10		6,726,578		6,726,578		3.11	$	0.10	$	0.10
$	0.12		6,226,000		6,226,000		0.93	$	0.12	$	0.12
$	0.14		5,000,000		5,000,000		2.81	$	0.14	$	0.14
$	0.15		2,107,667		2,107,667		1.83	$	0.15	$	0.15
$	0.17		27,993,325		27,993,325		2.90	$	0.17	$	0.17
$	0.18		850,000		850,000		0.03	$	0.18	$	0.18
$	0.25		3,700,000		3,700,000		1.02	$	0.25	$	0.25
$	0.30		2,500,000		2,500,000		0.35	$	0.30	$	0.30
			110,861,903		110,861,903

XML

Long Term Debt

3 Months Ended

Dec. 31, 2012

Convertible Notes, 12 Secured Promissory Note and Long Term Debt [Abstract]

Long Term Debt

Note 8 – Long Term Debt

10% Convertible Debt (WBI):

On November 26, 2012 Sionix completed the repurchase of all outstanding membership interests in WBI.  In return for their membership interests and the release of WBI from any future claims, the Company offered the members the option of receiving a pro-rata share of the remaining capital invested into WBI, or they could assign their rights to their remaining capital to Sionix in return for a convertible note issued by Sionix equal to 100% of their original investment. The pro-rata share calculation did not include Sionix's interest in WBI. The cash available for distribution totaled $854,046 or 63.3% of the original investment of $1,350,000. The Company returned $569,649 of the original capital invested, representing an original investment of $900,000.

The Company issued convertible notes in the amount of $450,000 and received $284,397 of the remaining capital.  In addition, the Company received $250,000 of new capital in return for the issuance of an additional note of $394,000, and recognized a debt discount of $144,000 in connection with this new note.

The convertible notes issued mature on September 30, 2014, bear an annual interest rate of 10% payable in cash or in kind at our election, and are convertible at the election of the holder into common shares of Sionix at a rate of $0.04.

As part of this offering, the Company paid a placement agent a fee of $45,000 for services rendered in connection with this transaction.

XML

Income Taxes

3 Months Ended

Dec. 31, 2012

Income Taxes [Abstract]

Income Taxes

Note 9 – Income Taxes

For the three months ended December 31, 2012, the accompanying Condensed Consolidated Statements of Operations reflect net income that is largely comprised of items that do not represent taxable income.

XML

Going Concern

3 Months Ended

Dec. 31, 2012

Going Concern [Abstract]

Going Concern

Note 11 – Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. This basis of accounting contemplates the recovery of the Company’s assets and the satisfaction of its liabilities in the normal course of business. Through December 31, 2012, the Company has incurred cumulative losses of $37,957,204 including a net loss for the three months ended December 31, 2012 of $1,057,909. As the Company has limited cash flow from operations, its ability to maintain normal operations is entirely dependent upon obtaining adequate cash to finance its overhead, research and development activities, and acquisition of production equipment. It is unknown when, if ever, the Company will achieve a level of revenues adequate to support its costs and expenses. In order for the Company to meet its basic financial obligations, including salaries, debt service and normal operating expenses, it plans to sell additional units of its water treatment system, and to seek additional equity or debt financing. Because of the Company’s history and current debt levels, there is considerable doubt that the Company will be able to obtain financing. The Company’s ability to meet its cash requirements for the next twelve months depends on its ability to obtain such financing. Even if financing is obtained, any such financing will likely involve additional fees and debt service requirements which may significantly reduce the amount of cash we will have for our operations. Accordingly, there is no assurance that the Company will be able to implement its plans.

As mentioned in Notes 5, 6, 7 and 8, the Company has related party notes, convertible notes, and subordinated debentures that have matured. The Company is continuing its efforts to obtain customers for its products, expand its sales efforts worldwide and expand the industries it targets for possible customers. The Company also has future plans for additional products, and revisions to its current products. In support of this the Company plans to hire additional personnel who have the industry experience and the training so that they can be immediately effective in the building of the Company. The Company retains most design, system configuration, and technical engineering resources “in-house.”  Certain design and specific research and development activities are periodically sub-contracted to its partner, Pacific Advanced Civil Engineering, Inc. (“PACE”) as access to scientific and engineering resources exceed Sionix “in-house” capability.  Only fabrication of the DAF component of our DAF system is sub-contracted, and then only for the construction of the stainless steel DAF tank.  With the exception of plumbing and electrical sub-contractors, all other fabrication and assembly activities are supervised and managed by “in-house” resources. This reduces costs and improves the quality of the Company's products. The Company is also continuing to seek additional investment capital in the form of debt or equity to continue operations, and is considering certain changes to its capital structure to become more attractive to potential investors and business partners.

XML

Stockholders' Equity (Details Textual) (USD $)	3 Months Ended
	Dec. 31, 2012	Sep. 30, 2012
Stockholders' Deficit (Textual)
Common stock, shares authorized	600,000,000	600,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	417,021,530	387,968,434
Common stock, shares outstanding	417,021,530	387,968,434
Common stock issued for services, shares	7,314,379
Common stock issued for services	$ 215,078
Number of shares of common stock issued for conversion of debt	21,738,717
Value of shares of common stock issued for conversion of debt including interest	433,764
Options and warrants granted to officers and employees	500,000
Warrant expiration period	5 years
Weighted average grant-date fair value of options and warrants	$ 14,671
Employee Stock Options and Warrants [Member]
Stockholders' Deficit (Textual)
Risk free rate of return	0.72%
Volatility	171.00%
Dividend yield	0.00%
Expected term	5 years

XML

Stockholders' Equity (Tables)

3 Months Ended

Dec. 31, 2012

Employee Stock Options and Warrants [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of the Company's activity for employee stock options/ stock warrants

	Number of Options			Weighted  Average  Exercise Price		Aggregate Intrinsic Value		Weighted  Average  Remaining  Contractual Life
Outstanding at October 1, 2012		43,716,316		$	0.12	$	-		3.01
Granted		500,000			0.15		-		4.75
Expired		(3,933,526	)		0.21		-		-
Forfeited		(500,000	)		0.15		-		-
Exercised		-			-		-		-
Outstanding at December 31, 2012		39,782,790			0.11		-		2.22
Exercisable at December 31, 2012		39,782,790		$	0.11	$	-		2.21

Schedule of options/warrants outstanding and exercisable

	Exercise Price	Options Outstanding		Contractual Life		Weighted Average Remaining Options Exercisable		Weighted Average Remaining Contractual Life
$	0.06		7,415,000		2.68		7,366,260		2.66
$	0.07		2,000,000		3.00		2,000,000		3.00
$	0.09		2,000,000		3.00		2,000,000		3.00
$	0.10		8,416,850		1.76		8,416,850		1.76
$	0.12		8,450,940		1.28		8,450,940		1.28
$	0.14		500,000		3.42		158,356		1.08
$	0.15		11,000,000		2.66		11,000,000		2.66
			39,782,790		2.22		39,392,406		2.21

Stock Warrants [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of the Company's activity for employee stock options/ stock warrants

	Number of Warrants			Weighted  Average  Exercise Price		Aggregate Intrinsic Value
Outstanding at October 1, 2012		114,460,085		$	0.12	$	75,000
Granted		625,000			0.08		-
Expired		(4,223,182	)		0.26		-
Forfeited		-			-		-
Exercised		-			-		-
Outstanding as of December 31, 2012		110,861,903		$	0.13	$	75,000
Exercisable as of December 31, 2012		110,861,903		$	0.12	$	75,000

Schedule of options/warrants outstanding and exercisable

						Weighted
						Average
						Remaining		Weighted Average
	Exercise	Warrants		Warrants		Contractual		Exercise Price
	Price	Outstanding		Exercisable		Life		Outstanding		Exercisable
$	0.06		7,500,000		7,500,000		3.38	$	0.06	$	0.06
$	0.07		22,833,333		22,833,333		1.29	$	0.07	$	0.07
$	0.08		25,425,000		25,425,000		4.73	$	0.08	$	0.08
$	0.10		6,726,578		6,726,578		3.11	$	0.10	$	0.10
$	0.12		6,226,000		6,226,000		0.93	$	0.12	$	0.12
$	0.14		5,000,000		5,000,000		2.81	$	0.14	$	0.14
$	0.15		2,107,667		2,107,667		1.83	$	0.15	$	0.15
$	0.17		27,993,325		27,993,325		2.90	$	0.17	$	0.17
$	0.18		850,000		850,000		0.03	$	0.18	$	0.18
$	0.25		3,700,000		3,700,000		1.02	$	0.25	$	0.25
$	0.30		2,500,000		2,500,000		0.35	$	0.30	$	0.30
			110,861,903		110,861,903

XML

Notes Payable - Related Parties (Details) (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Sep. 30, 2012
Notes Payable - Related Parties (Textual)
Maximum interest rate of notes	10.00%
Notes payable - related parties	$ 25,000		$ 25,000
Accrued interest on the notes	20,356		19,717
Interest Expense	$ 639	$ 639

XML

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities
Net loss	$ (1,057,909)	$ (1,194,502)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation	10,068	3,506
Amortization of debt discounts	228,037	100,983
Share based payments	14,671	103,932
Common stock issued for services	215,078	239,500
(Gain) loss on change in fair value of derivative liability	(78,191)	(325)
Loss on sale of property and equipment	2,228
Gain on settlement of debt	(4,031)	(41,911)
Changes in operating assets and liabilities:
Inventory	(100,135)	(16,871)
Other current assets	(100,864)	(264,661)
Accounts payable	(129,760)	51,650
Accrued expenses	54,073	398,027
Deferred revenue
Net cash used by operating activities	(946,735)	(620,672)
Cash flows from investing activities:
Proceeds from sale of property and equipment	41,171
Purchase of property and equipment	(5,748)
Net cash provided by investing activities	35,423
Cash flows from financing activities:
Borrowings	273,125	491,500
Common stock issued for cash		150,200
Cash issued in redemption of subsidiary interests	(569,647)
Net cash (used) provided by financing activities	(296,522)	641,700
Net (decrease) increase in cash and cash equivalents	(1,207,834)	21,028
Cash and cash equivalents, beginning of period	1,348,069	685
Cash and cash equivalents, end of period	140,235	21,713
SUPPLEMENTARY CASH FLOW INFORMATION:
Income taxes paid	1,095	599
Interest paid
Debt issued in redemption of subsidiary interests	$ 450,000

XML

Notes Payable - Related Parties

3 Months Ended

Dec. 31, 2012

Notes Payable - Related Parties [Abstract]

Notes Payable - Related Parties

Note 5 – Notes Payable – Related Parties

The Company has received advances in the form of unsecured promissory notes from stockholders. The original date of these advances was November 2009, March 2011 and October 2011. These notes bear interest at rates up to 10% and are due on demand. As of both December 31, 2012 and September 30, 2012, such notes payable amounted to $25,000. Accrued interest on the notes amounted to $20,356 and $19,717 at December 31, 2012 and September 30, 2012, respectively, and is included in accrued expenses. Interest expense on these notes for the three months ended December 31, 2012 and 2011 amounted to $639 and $639, respectively. No demand for payment has been made as of December 31, 2012.

XML

Convertible Notes (Details) (USD $)	3 Months Ended			1 Months Ended		3 Months Ended						2 Months Ended	12 Months Ended			3 Months Ended			3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Sep. 30, 2012	Sep. 30, 2012 6% Convertible Redeemable Note	Nov. 30, 2011 6% Convertible Redeemable Note	Dec. 31, 2012 6% Convertible Redeemable Note	Feb. 19, 2013 6% Convertible Redeemable Note	Sep. 21, 2012 6% Convertible Redeemable Note	Nov. 23, 2011 6% Convertible Redeemable Note	Dec. 31, 2012 6% Convertible Redeemable Note November 23, 2011 [Member]	Dec. 31, 2012 6% Convertible Redeemable Note September 21, 2012 [Member]	Feb. 19, 2013 10% Convertible Debentures	Sep. 30, 2012 10% Convertible Debentures	Nov. 26, 2012 10% Convertible Debentures	Sep. 29, 2012 10% Convertible Debentures	Dec. 31, 2012 Minimum [Member]	Feb. 19, 2013 Minimum [Member] 10% Convertible Debentures	Sep. 30, 2012 Minimum [Member] 10% Convertible Debentures	Dec. 31, 2012 Maximum [Member]	Feb. 19, 2013 Maximum [Member] 10% Convertible Debentures	Sep. 30, 2012 Maximum [Member] 10% Convertible Debentures
Convertible Notes (Textual)
Convertible notes payable	$ 1,983,358		$ 1,895,378						$ 400,000
Discount on convertible note payable	344,464		383,600
Interest rate on convertible note						6.00%							10.00%			6.00%			12.00%
Per share price of conversion of debt into common stock																$ 0.02			$ 0.05
Interest rate on convertible redeemable note							6.00%	6.00%	6.00%			10.00%
Convertible debentures issued, Amount	700,000
Unsecured convertible, carrying amount of equity component	87,500
Change in fair value of derivative liability	78,191	325
Conversion of notes payable into common stock	82,500
Conversion of notes payable into common stock, shares	8,569,317
Convertible redeemable note, face amount								100,000	100,000			140,000
Convertible notes maturity date	Sep. 30, 2014			Sep. 21, 2013	Nov. 23, 2012
Convertible instrument, maturity, start date													Sep. 25, 2012
Convertible instrument, maturity, end date													Jun. 25, 2013
Convertible notes, fee amount								6,000	45,000
Debt outstanding amount										36,600	100,000
Convertible redeemable note subject to redemption, settlement terms, description				An optional right of redemption prior to maturity upon a five-day notice and payment of a 50% premium on the unpaid principal amount of the loan.									The Notes may be redeemed by the Company at any time prior to maturity with ten days' prior notice to the Holders, and payment of a premium of 25% on the unpaid principal amount of the Notes.
convertible debt, convertible, terms of conversion feature				The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.	The conversion price for each share of common stock will be equal to 70% of the lowest closing bid price of the common stock for a period of five trading days, but no lower than $0.001 per share.							The notes are convertible at any time at the option of the holders into shares of our common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request.	The Notes are convertible at any time at the option of the Holders into the Company's common stock at a conversion price based on 80% of the average of the three lowest closing prices for the common stock during the ten consecutive trading days immediately preceding the conversion request.
Maximum period to file registration statement													30 days
Description for obligations in failure of filling registration statement													If the Company fails to file a registration statement within this 30 day period, or to have it declared effective within 90 days after the date of the registration rights agreement, or to maintain its effectiveness (in addition to other events described in the full text of the registration rights agreement), the Company will be obligated to pay the investors liquidated damages equal to 2% of the principal amount of the Notes per month until the event is cured, for up to one year, and 1% per month thereafter if the event continues uncured.
Convertible notes, additional funding provided by lender to the company in the form of a promissory note				300,000	300,000
Availability of promissory note in additional funding on each of June 1, 2012, July 1, 2012 and August 1, 2012				100,000
Convertible notes conversion price									$ 0.001			$ 0.02		$ 0.04		$ 0.02	$ 0.02	$ 0.02	$ 0.15	$ 0.04	$ 0.04
Sale of convertible debt to accredited investor													1,025,000
Debt instrument maturity period													9 months
Number of shares to be purchased from issuance of warrants	2,083,334														23,125,000
Warrant vesting period													5 years
Warrants, exercise price	$ 0.06												$ 0.08
Cash fee paid to the placement agent													$ 87,535
Percentage of gross proceeds of primary debentures paid as placement fee to agent													8.54%

XML

Accrued Expenses (Tables)

3 Months Ended

Dec. 31, 2012

Accrued Expenses [Abstract]

Components of Accrued expenses

	December 31, 2012		September 30, 2012
Accrued salaries	$	281,752	$	306,055
Interest payable		415,876		364,567
Other accrued expenses		247,105		237,106
Total accrued expenses	$	944,733	$	907,728